QUESTIONABLE PHARMA: UNVEILING THE ISSUES

The term " Disreputable Pharma" has emerged recently, igniting a heated discussion surrounding certain pharmaceutical companies . Allegations of deceptive marketing practices, inflated drug rates, and a suspected disregard for patient well-being have resulted in increasing scrutiny from watchdogs